Review: taking Baclofen and Gabapentin together


Summary

Drug interactions are reported among people who take Baclofen and Gabapentin together. This review analyzes the effectiveness and drug interactions between Baclofen and Gabapentin. It is created by eHealthMe based on reports of 5,778 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Baclofen and Gabapentin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Baclofen

Baclofen has active ingredients of baclofen. It is often used in muscle spasticity. (latest outcomes from Baclofen 28,487 users)

Gabapentin

Gabapentin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Gabapentin 52,972 users)

On Aug, 29, 2016

5,778 people who take Baclofen, Gabapentin are studied.


Number of reports submitted per year:

Baclofen and Gabapentin drug interactions.

Drug effectiveness over time:

Baclofen:
  • < 1 month: 15.0% - (2 of 13 people)
  • 1 - 6 months: 17.0% - (4 of 23 people)
  • 6 - 12 months: 0.0% - (0 of 14 people)
  • 1 - 2 years: 32.0% - (10 of 31 people)
  • 2 - 5 years: 31.0% - (12 of 38 people)
  • 5 - 10 years: 34.0% - (8 of 23 people)
  • 10+ years: 47.0% - (8 of 17 people)
  • not specified: 0.0% - (0 of 3 people)
Gabapentin:
  • < 1 month: 33.0% - (3 of 9 people)
  • 1 - 6 months: 10.0% - (3 of 28 people)
  • 6 - 12 months: 7.0% - (1 of 13 people)
  • 1 - 2 years: 20.0% - (5 of 25 people)
  • 2 - 5 years: 31.0% - (11 of 35 people)
  • 5 - 10 years: 30.0% - (9 of 30 people)
  • 10+ years: 44.0% - (8 of 18 people)
  • not specified: 25.0% - (1 of 4 people)

Drug effectiveness by gender:

Baclofen:
  • female: 26.0% - (30 of 113 people)
  • male: 28.0% - (14 of 49 people)
Gabapentin:
  • female: 24.0% - (27 of 111 people)
  • male: 27.0% - (14 of 51 people)

Drug effectiveness by age:

Baclofen:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 40.0% - (2 of 5 people)
  • 30-39: 39.0% - (13 of 33 people)
  • 40-49: 19.0% - (9 of 47 people)
  • 50-59: 29.0% - (15 of 51 people)
  • 60+: 20.0% - (5 of 24 people)
Gabapentin:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 5 people)
  • 30-39: 22.0% - (8 of 35 people)
  • 40-49: 33.0% - (15 of 45 people)
  • 50-59: 22.0% - (11 of 50 people)
  • 60+: 28.0% - (7 of 25 people)

Most common drug interactions over time *:

< 1 month:
  • pulmonary embolism
  • acute respiratory distress syndrome
  • anoxic encephalopathy
  • confusional state
  • dizziness
  • vena cava thrombosis
  • drug withdrawal syndrome
  • somnolence
  • dyskinesia
  • clostridium difficile colitis
1 - 6 months:
  • confusional state
  • fatigue
  • dizziness
  • hypertension
  • diarrhoea
  • erectile dysfunction
  • haemarthrosis
  • malaise
  • pain
  • abdominal pain
6 - 12 months:
  • chest pain
  • fatigue
  • depression
  • anaemia
  • anterior knee pain
  • arthroscopic surgery
  • back pain
  • feeling abnormal
  • gait abnormal
  • hip pain
1 - 2 years:
  • dizziness
  • leg pain
  • muscle weakness
  • sleeplessness
  • drug ineffective
  • feeling abnormal
  • convulsion
  • erythema
  • leg cramps
  • muscle cramps
2 - 5 years:
  • pain
  • nausea
  • depression
  • pneumonia
  • anxiety
  • multiple sclerosis
  • hearing loss
  • tinnitus
  • weight decreased
  • diarrhoea
5 - 10 years:
  • red blood cell count decreased
  • pneumonia
  • hypoxia
  • depression
  • enlarged prostate
  • gallstones
  • herniated nucleus pulposus (slipped disk)
  • low back pain
  • neuropathy peripheral
  • renal cyst
10+ years:
  • swollen tongue
  • eczema eyelids
  • hyperkalaemia
  • swelling face
  • kidney crystallisation
  • chf
  • dysphagia
  • edema - peripheral, peripheral edema
  • paraplegia
  • renal insufficiency
not specified:
  • fall
  • pain
  • fatigue
  • nausea
  • headache
  • multiple sclerosis relapse
  • depression
  • dyspnoea
  • dizziness
  • asthenia

Most common drug interactions by gender *:

female:
  • fall
  • nausea
  • fatigue
  • headache
  • pain
  • multiple sclerosis relapse
  • urinary tract infection
  • asthenia
  • dizziness
  • dyspnoea
male:
  • pain
  • fatigue
  • depression
  • fall
  • muscle spasms
  • nausea
  • anxiety
  • drug ineffective
  • pain in extremity
  • dizziness

Most common drug interactions by age *:

0-1:
  • alopecia
  • cellulitis
  • contusion
  • drug withdrawal syndrome neonatal
  • fall
  • foetal exposure during pregnancy
  • foetal growth restriction
  • hypokalaemia
  • hyponatraemia
  • hypophosphataemia
2-9:
  • vomiting
  • convulsion
  • muscular weakness
  • pneumonia
  • asthenia
  • nausea
  • multiple sclerosis
  • multiple sclerosis relapse
  • urinary tract infection
  • dehydration
10-19:
  • dizziness
  • memory impairment
  • amnesia
  • disturbance in attention
  • fear of disease
  • infective tenosynovitis
  • laboratory test abnormal
  • mental disorder
  • mental impairment
  • toxic skin eruption
20-29:
  • pain
  • multiple sclerosis
  • dyspnoea
  • fatigue
  • multiple sclerosis relapse
  • muscle spasms
  • diarrhoea
  • nausea
  • hypoaesthesia
  • abasia
30-39:
  • depression
  • fatigue
  • headache
  • hypoaesthesia
  • multiple sclerosis relapse
  • muscle spasms
  • pain in extremity
  • nausea
  • pyrexia
  • fall
40-49:
  • nausea
  • fatigue
  • pain
  • headache
  • fall
  • multiple sclerosis relapse
  • depression
  • dyspnoea
  • asthenia
  • muscle spasms
50-59:
  • fall
  • pain
  • nausea
  • arthralgia
  • anxiety
  • depression
  • diarrhoea
  • dyspnoea
  • dizziness
  • headache
60+:
  • fall
  • fatigue
  • pain
  • nausea
  • dizziness
  • urinary tract infection
  • headache
  • gait disturbance
  • muscle spasms
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Baclofen and Gabapentin?

Can you answer these questions?

More questions for: Baclofen, Gabapentin

You may be interested in these reviews

More reviews for: Baclofen, Gabapentin

On eHealthMe, Baclofen (baclofen) is often used to treat muscle spasticity. Gabapentin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.